Supercritical rosemary extract effect on SW620 colon cancer cells: dose response
Summary:
Analysis of adenocarcinoma derived-SW620 colon cancer cells treated with supercritical rosemary extract (RE-2) at doses of 30, 60 and 100 μg/mL. RE contains carnosic acid and carnosol (diterpenes) and essential oils. Results provide insight into the molecular basis of RE's anticancer effects.
GPL6480:
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version)
Citation:
González-Vallinas M, Molina S, Vicente G, Zarza V et al. Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancer. PLoS One 2014;9(6):e98556. PMID: 24892299
